FDA Investigator Bichsa T Tran

Bichsa T Tran has conducted inspections on 34 sites in 4 countries as of 19 Apr 2017. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
34
Last Inspection Date:
19 Apr 2017
Investigator Role:
FDA Investigator
Redica ID:
100004856
Countries of Inspections:
United States of America, Switzerland, India, Japan
FDA Investigators that have inspected at least one site in common with Bichsa T Tran:
Adam R Cooke, Ademola O Daramola, Alan P Kurtzberg, Alexandra B Pitkin, Althea A Williams, Amalia C Himaya, Amanda L Fyles, Amir Alavi, Anastasia M Shields, Anderson, Andrea A Branche, Andrew K Haack, PhD, Andrew S Limson, Andy B Lee, Angela Shepas, Angele C Smith, Anita Narula, PhD, Anthony G Emerson, April C Inyard, April P Shaw, Arie C Menachem, Ariel Cruz Figueroa, Arsen Karapetyan, Ashar P Parikh, Barbara I Rogolsky, Barbara J Rincon, Barry Cherney, PhD, Benjamin S Liao, Bijoy Panicker, Binh T Nguyen, Blondell W Johnson, Bo Chi, PhD, Brian D Nicholson, Brien C Fox, Bryan A Galvez, Calvin B Koerner, Carla J Lundi, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Cathleen A Carr Sharpe, Charles M Edwards, Cheron M Portee, Christina C Santos, Christina K Theodorou, Christina V Santos, Christopher R Czajka, Claudia Mperez Kasmarski, Comyar Shoghi, Conner N Mann, Crystal Monroy, Daniel J Roberts, Daniel W Cline, Darla J Christopher, Darren S Brown, David Serrano, Davinna Ligons, PhD, Dawn E Barkans, Deborah A Greco, Dejon N Harris, Diana M Rand, Diane Cvan Leeuwen, Diane L Raccasi, Dipesh K Shah, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Donna Ltartaglino Besone, Dr. Chunchang Fang, Dr. Mark J Seaton, PhD, Dr. Monica D Cooper, Durell L Giles, Dyana K Stone, Eileen A Liu, Elaine A Bunch, Elizabeth Ad Girard, Esther C Broner, PhD, Evelyn Wong, Finn A Slizza, Frances Namuswe, PhD, Frederick L Fricke, Gabriel Craig, Gene D Arcy, Gregory A Berg, Haley H Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Himanshu Gupta, PhD, Homero W Aguilar, Hossein Khorshidi, PhD, Iris C Macinnes, Jacob W Reynolds, James A Barreto, James B Arnett, James C Maclaughlin, James P Stumpff, James R Fleckenstein, Jamie M Du, Jane S Wernberg, Janet D Blount, Jasmine N Thompson, Jee Chung, PhD, Jeffery A Johnson, Jeffrey P Raimondi, Jennifer Gogley, Jennifer M Gogley, Jeremy W Rotton, Jessica L Pressley, Jinnie Kokiatkulkij, Jocelyn E Massey, Jocelyn E Sparks, Joe X Phillips, Joel D Hustedt, Joel Welch, PhD, Joey V Quitania, John A Gonzalez, John L Stevens, John R Myung, Jolanna A Norton, Joseph X Phillips, Juanita Banuelos, Juanj N Wu, Julia Ventura, Junho Pak, Ka L Wong, Karen A Wolnik, Kari M Johansen, Katherine E Jacobitz, Katherine Szestypalow, Kathleen R Jones, PhD, Kathy Chiu, Kathy Kuo, Keith P Iams, Kelley, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kenneth R Merritt, Kevin N Tran, Kham Phommachanh, Kim Lthomas Cruse, Kirtida Patel, Lakecha N Lewis, Larry K Austin, Laura Fontan, MS, Lauren L Vajo, Lavender M Huskey, Leonard H Lavi, Lillian S Wu, Lillie D Witcher, Lilly O Barton, Liming Zhang, Linda F Murphy, Linda Linh N Adams, Linda Thai, Ling Yu L Liu, Lixia Cai, Loretta J Jordan, Mai X Huynh, Marcia B Williams, Marco S Esteves, Marcus F Yambot, Marie Falcone, Marie T Falcone, Mariza M Jafary, Mark C Saale, Mark W Babbitt, Marvin D Jones, Matthew B Casale, Maurice M Sheehan, Maxyne T Lam, Michael D Garcia, Michael T Cyrus, Michelle A Marsh, Michelle J Hines, Miguel A Martinez Perez, Mihaly S Ligmond, Minh D Phan, Mohsen Rajabi Abhari, FDA, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nayan J Patel, Nelly N Tran, Nicholas L Hunt, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Nicole E Knowlton, Olusegun J Ajayi, Omotunde O Osunsanmi, Pal S Mayasandra, Paquita F Segarra, Paul A Bonneau, Peter C Chow, Peter S Diak, Philip F Istafanos, DMV, MS, Prabhu P Raju, Rachel C Stanton, Rajiv R Srivastava, Randall N Johnson, Raymond T Oji, Raymond W Brullo, Reba A Gates, Rebecca Rodriguez, Richmond K Yip, Robert C Coleman, Robert D Tollefsen, Robert Darius, Roger F Zabinski, Rona Leblanc, PhD, Ronald L Koller, Ronda Leblanc, Ross J Grigsby, Rumany C Penn, PharmD, Ruth A Williams, Saied A Asbagh, Sandra A Boyd, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Santos E Camara, Sarah Arden, Scott R Nichols, PhD, Selene T Torres, Shannon B Ruelle, Shirley J Berryman, Sidney B Priesmeyer, Sonia R Peterson, Sonya L Karsik, RAC, Sparky L Bartee, Srinivas R Chennamaneni, PhD, Stanley Au, Steven A Brettler, Steven E Porter, Jr, Steven Fong, MS, PhD, Sue Lee Chan, Sumit Sen, Sundy V Sedwick, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Tamika White, Teresa I Navas, Teresa T Cain, Terrance L Thomas, Terri L Dodds, Thao T Kwan, Thao X Tran, Theresa Kirkham (NMI), Thomas J Arista, Thomas R Beilke, Timothy P Lafave, Timothy T Kapsala, Tony J Wu, Torrance J Slayton, Tracey T Duong, Trudy R Papson, Truong Xuan Nguyen (Andy), Tuan A Nguyen, Uttaniti Limchumroon (Tom), Vaishali J Patel, Valerie L Whipp, Vashti E Bocker, Vickie L Anderson, Vien Q Le, Virgilio F Pacio, CSO, Walden H Lee, Wenzheng Wendy Zhang, William J Leonard, Xiaohan Cai, PhD, Xiaohui Shen, Yasamin Ameri, Yumi J Hiramine, Yvette E Guillermo, Yvette Mlacour Davis, Yvonne C Wilkes, Yvonne Y Wu, Zachary A Bogorad, Zedong Dong, Zhaoyang Meng

Bichsa T Tran's Documents

Publish Date Document Type Title
July, 2016 FDA 483 Response Teva Parenteral Medicines, Inc. - Form 483R, 2016-08-19
September, 2012 FDA 483 Titan Medical Enterprises, Inc. DBA U.S. Apothecary Labs - Form 483, 2012-09-12
November, 2007 FDA 483 Abbott Vascular Inc - Form 483, 2007-11-15
February, 2006 FDA 483 CATALENT SAN DIEGO, INC. - Form 483, 2006-02-23
April, 2017 FDA 483 Nitto Avecia Pharma Services, Inc. - Form 483, 2017-04-21
November, 2006 FDA 483 Cephazone Pharma LLC - Form 483, 2006-11-06
February, 2006 FDA 483 Spectrum Pharmaceuticals, Inc. - Form 483, 2006-02-23
February, 2013 FDA 483 ADAMSON ANALYTICAL LABORATORIES INC - Form 483, 2013-02-07
December, 2003 FDA 483 Amgen, Inc - Form 483, 2003-12-12
September, 2003 FDA 483 Med-Pharmex, Inc - Form 483, 2003-09-12
July, 2004 EIR La Jolla Pharmaceutical Co. - EIR, 2004-07-23
July, 2016 EIR Teva Parenteral Medicines, Inc. - EIR, 2016-07-29
April, 2017 EIR Nitto Avecia Pharma Services, Inc. - EIR, 2017-04-21
April, 2012 EIR Teva Parenteral Medicines, Inc. - EIR, 2012-04-24
February, 2004 FDA 483 Defender SD Manufacturing LLC - Form 483, 2004-02-24
December, 2003 FDA 483 Response Amgen, Inc - Form 483R, 2004-01-06
July, 2004 FDA 483 La Jolla Pharmaceutical Co. - Form 483, 2004-07-23
December, 2003 EIR Amgen, Inc - EIR, 2003-12-12
April, 2012 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2012-04-24
July, 2016 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2016-07-29
October, 2006 FDA 483 Response UFAG Laboratorien AG - Form 483R, 2006-10-23
March, 2008 FDA 483 Alliance Medical Products, Inc. (dba Siegfried Irvine) - Form 483, 2008-03-11
May, 2004 FDA 483 Watson Laboratories, Inc. - Form 483, 2004-05-06
August, 2014 FDA 483 Amphastar Pharmaceuticals, Inc. - Form 483, 2014-08-08
October, 2006 EIR UFAG Laboratorien AG - EIR, 2006-10-09
October, 2006 FDA 483 UFAG Laboratorien AG - Form 483, 2006-10-09
February, 2004 EIR Defender SD Manufacturing LLC - EIR, 2004-02-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more